Concord Biotech bonus issue: 1:1 issue proposed via postal ballot
Company seeks shareholder approval by postal ballot for a 1:1 bonus equity share issue and a hike in authorised capital to Rs 22,00,00,000.
Key takeaways
- 1:1 bonus equity share issue proposed, 1 share of Rs 1/- for every 1 existing share
- Rs 10,46,16,204/- to be capitalised from the securities premium account for the bonus
- Authorised share capital proposed to rise to Rs 22,00,00,000/- divided into 22,00,00,000 shares
- Cut-off date for voting eligibility is September 18, 2026; e-voting runs to October 24, 2026
- Record Date for bonus entitlement will be fixed by the Board and is not stated in the notice
Key terms
- Action
- Bonus issue
- Terms
- 1 (One) Equity Shares of Rs 1/- each as bonus share for every 1 (One) existing Equity Share
- Remote e-voting period: September 25, 2026 to October 24, 2026
- Bonus shares to be issued by capitalising Rs 10,46,16,204/- from securities premium
Concord Biotech Limited has launched a postal ballot process to seek shareholder approval for a proposed bonus equity share issue and a corresponding increase in its authorised share capital.
According to the Postal Ballot Notice dated September 23, 2026, circulated under Regulation 30 of the SEBI (LODR) Regulations, 2015, members will vote only through remote e-voting.
Key terms (as per Postal Ballot Notice)
- Bonus ratio: 1 (One) Equity Share of Rs 1/- each as bonus for every 1 (One) existing Equity Share held (1:1)
- Face value: Rs 1/- (Rupees one only) per Equity Share
- Capitalisation amount for bonus: Rs 10,46,16,204/- (Rupees Ten Crores Forty-Six Lakhs Sixteen Thousand Two hundred and four only) from the securities premium account (Item 2 resolution)
- Existing authorised share capital: Rs 11,00,00,000/- divided into 11,00,00,000 Equity Shares of Rs 1/- each (Item 1 resolution and explanatory statement)
- Proposed authorised share capital: Rs 22,00,00,000/- divided into 22,00,00,000 Equity Shares of Rs 1/- each (Item 1 resolution)
- Existing paid-up share capital: Rs 10,46,16,204/- divided into 10,46,16,204 Equity Shares of Rs 1 each, fully paid-up (explanatory statement, Item No. 1 and 2)
- Cut-off date for voting eligibility: September 18, 2026 (Notes, point 5 and point 7)
- Remote e-voting period: Starts on September 25, 2026 and ends on October 24, 2026 (Postal Ballot Notice header table and Notes, point 7)
- Deemed date of passing resolutions (if approved): October 24, 2026 (Notes, point 13)
What the bonus issue is
Under Resolution 2 (Issuance of Bonus Equity Shares), the company is seeking members’ consent to:
“capitalize a sum of Rs 10,46,16,204/- ... out of the securities premium account of the Company for the purpose of issuing Bonus Equity Shares to the members of the Company, by issue and allotment of 1 (One) Equity Shares of Rs 1/- ... as bonus share, credited as fully paid-up, for every 1 (One) existing Equity Share held by the members whose names appear in the Register of Members as on the Record Date to be fixed by the Board of Directors of the Company.”
The explanatory statement (Item No. 1 and 2) reiterates that the Board, at its meeting held on September 23, 2026, approved and recommended to the members the issuance of 1 (One) bonus equity share of face value of Rs 1/- each for every 1 (One) fully paid-up equity share of face value of Rs 1/- each held as on the Record Date to be decided by the Board.
The bonus equity shares, once issued, will rank pari passu in all respects with the existing fully paid-up equity shares, including in respect of dividend and other corporate benefits, from such date as may be applicable in accordance with law (Resolution 2). The explanatory statement also notes that, in line with Regulation 295 of the SEBI ICDR Regulations, the proposed bonus issue shall be implemented within two months from September 23, 2026, subject to member approval.
Eligibility and record date
Eligibility for the bonus will be based on the Record Date that will be fixed by the Board of Directors. The exact record date is not stated in the Postal Ballot Notice. Investors holding fully paid-up equity shares as on that record date, with their names appearing in the Register of Members, will be entitled to receive the bonus shares.
The September 18, 2026 cut-off date mentioned in the Notes is only for determining which members are entitled to receive the Postal Ballot Notice and to vote by remote e-voting. It is not the bonus issue record date.
Increase in authorised share capital
To enable the bonus issue and meet future capital requirements, Resolution 1 seeks approval to increase the authorised share capital:
- From Rs 11,00,00,000/-, divided into 11,00,00,000 Equity Shares of Rs 1/- each
- To Rs 22,00,00,000/-, divided into 22,00,00,000 Equity Shares of Rs 1/- each, by creation of an additional 11,00,00,000 (Eleven Crores) Equity Shares of Rs 1/- each.
Clause V of the Memorandum of Association is proposed to be altered accordingly, with the new clause stating:
“The Authorized Share Capital of the Company is Rs 22,00,00,000/- ... divided into 22,00,00,000 (Twenty-Two Crores) Equity Shares of Rs 1/- each (Rupees One only).”
Company’s stated rationale
In the explanatory statement (Item No. 1 and 2), the Board states that the bonus issue and related capital increase are intended:
- “with a view to rewarding the Members for their continued support”
- and to “encouraging wider participation by investors by making the equity shares of the Company more affordable and enhancing the liquidity of the equity shares”.
The Board states that it is of the view that the proposed bonus issue is in the interest of the company and its existing and prospective investors and therefore recommends Resolutions Nos. 1 and 2 for member approval by way of Ordinary Resolutions.
No buyback, dividend amount or dividend record date is proposed or mentioned in this Postal Ballot Notice.
Track Concord Biotech Ltd
Cruxal reads every Concord Biotech Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Get every filing that moves a stock
One email before the open, with the day's filings that actually shifted a price — the number, the source document and what the market did with it. Free, and you can unsubscribe from any issue.
Cruxal publishes market coverage for information only. Nothing here is investment advice.